Address
Email address
Phone number
Website
https://handal.netHandal - Egiptuse Salv Colocynth leevendab lihaspinged ja lihasvalu.Egiptuse Salv Colocynth on 100 % looduslik salv. Liigesevaludest vabanemine taimsete õlide abil. Lihaspinged ja lihasvalu kontrolli alla. Tõhus spordisalv.
Name
OÜ Handal Trade
Registry code
11085100
VAT number
EE101056665
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.11.2004 (20)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing Abovo Grupp 11360210 | 100% - 2 556.00 EUR | - | - | |
| Omanikukonto: Kaur Kuurme 17.02.1978 (46) | - | Board member | Direct ownership | |
| Urmas Toome 24.05.1975 (49) | - | - | - | Founder |
| 2019 31.10.2020 | 2020 10.02.2021 | 2021 28.04.2022 | 2022 11.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 6 973 € | 6 787 € | 5 875 € | 5 670 € |
| Net profit (loss) for the period | 1 068 € | 1 266 € | 606 € | -106 € |
| Profit Margin | 15% | 19% | 10% | -2% |
| Current Assets | 8 556 € | 5 066 € | 6 548 € | 5 728 € |
| Fixed Assets | 0 € | 0 € | 0 € | 0 € |
| Total Assets | 8 556 € | 5 066 € | 6 548 € | 5 728 € |
| Current Liabilities | 153 € | 191 € | 267 € | 153 € |
| Non Current Liabilities | 5 294 € | 500 € | 1 300 € | 700 € |
| Total Liabilities | 5 447 € | 691 € | 1 567 € | 853 € |
| Share Capital | - | - | - | - |
| Equity | 3 109 € | 4 375 € | 4 981 € | 4 875 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 835.62 € | 47.19 € | - | - |
| 2023 Q4 | 2 030.98 € | 267.88 € | - | - |
| 2023 Q3 | 512.08 € | 32.82 € | - | - |
| 2023 Q2 | 1 589.74 € | 89.11 € | - | - |
| 2023 Q1 | 1 406.6 € | 69.42 € | - | - |
| 2022 Q4 | 1 689.52 € | 205.21 € | - | - |
| 2022 Q3 | 1 017.49 € | 98.72 € | - | - |
| 2022 Q2 | 1 866.21 € | 184.84 € | - | - |
| 2022 Q1 | 2 074.21 € | 233.12 € | - | - |
| 2021 Q4 | 1 525.51 € | - | - | - |
| 2021 Q3 | 894.53 € | 107.15 € | - | - |
| 2021 Q2 | 1 768.41 € | 267.87 € | - | - |
| 2021 Q1 | 1 576.34 € | 242.58 € | - | - |
| 2020 Q4 | 1 983.45 € | 252.21 € | - | - |
| 2020 Q3 | 1 625.39 € | 213.27 € | - | - |
| 2020 Q2 | 1 046.95 € | 127.92 € | - | - |
| 2020 Q1 | 1 517.94 € | 114.33 € | - | - |
